Inhibikase Therapeutics to Report Full Year 2021 Financial Results on March 31, 2022
- Friday, March 25, 2022, 7:02
- Finance
- Add a comment
BOSTON and ATLANTA, Mar. 25, 2022 /PRNewswire/ — Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing therapeutics to modify the course of Parkinson’s disease and related disorders, today announced that it will report financial…
About the Author
adminasapcorp has written 41775 stories on this site.